Literature DB >> 19488988

HOX D13 expression across 79 tumor tissue types.

Monica Cantile1, Renato Franco, Adrienne Tschan, Daniel Baumhoer, Inti Zlobec, Giulia Schiavo, Iris Forte, Michel Bihl, Giuseppina Liguori, Gerardo Botti, Luigi Tornillo, Eva Karamitopoulou-Diamantis, Luigi Terracciano, Clemente Cillo.   

Abstract

HOX genes control normal development, primary cellular processes and are characterized by a unique genomic network organization. Locus D HOX genes play an important role in limb generation and mesenchymal condensation. Dysregulated HOXD13 expression has been detected in breast cancer, melanoma, cervical cancer and astrocytomas. We have investigated the epidemiology of HOXD13 expression in human tissues and its potential deregulation in the carcinogenesis of specific tumors. HOXD13 homeoprotein expression has been detected using microarray technology comprising more than 4,000 normal and neoplastic tissue samples including 79 different tumor categories. Validation of HOXD13 expression has been performed, at mRNA level, for selected tumor types. Significant differences are detectable between specific normal tissues and corresponding tumor types with the majority of cancers showing an increase in HOXD13 expression (16.1% normal vs. 57.7% cancers). In contrast, pancreas and stomach tumor subtypes display the opposite trend. Interestingly, detection of the HOXD13 homeoprotein in pancreas-tissue microarrays shows that its negative expression has a significant and adverse effect on the prognosis of patients with pancreatic cancer independent of the T or N stage at the time of diagnosis. Our study provides, for the first time, an overview of a HOX protein expression in a large series of normal and neoplastic tissue types, identifies pancreatic cancer as one of the most affected by the HOXD13 hoemoprotein and underlines the way homeoproteins can be associated to human cancerogenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19488988     DOI: 10.1002/ijc.24438

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  22 in total

1.  Identification of methylation profile of HOX genes in extrahepatic cholangiocarcinoma.

Authors:  Yi Shu; Bing Wang; Ji Wang; Jian-Ming Wang; Sheng-Quan Zou
Journal:  World J Gastroenterol       Date:  2011-08-07       Impact factor: 5.742

2.  Deregulation of paralogous 13 HOX genes in oral squamous cell carcinoma.

Authors:  Gabriella Aquino; Renato Franco; Rocco Sabatino; Elvira La Mantia; Giosuè Scognamiglio; Francesca Collina; Francesco Longo; Franco Ionna; Nunzia S Losito; Giuseppina Liguori; Gerardo Botti; Monica Cantile
Journal:  Am J Cancer Res       Date:  2015-09-15       Impact factor: 6.166

3.  Hox B4 as potential marker of non-differentiated cells in human cervical cancer cells.

Authors:  Ana P Barba-de la Rosa; Erika Briones-Cerecero; Ofelia Lugo-Melchor; Antonio De León-Rodríguez; Leticia Santos; Julio Castelo-Ruelas; Alejandra Valdivia; Patricia Piña; Alicia Chagolla-López; Daniel Hernandez-Cueto; Alejandra Mantilla; Minerva Lazos-Ochoa; Beatriz Gonzalez-Yebra; Mauricio Salcedo
Journal:  J Cancer Res Clin Oncol       Date:  2011-11-27       Impact factor: 4.553

4.  Prognostic significance of HOXD13 expression in human breast cancer.

Authors:  Zhen-Bin Zhong; Ming Shan; Cheng Qian; Tong Liu; Qing-Yu Shi; Ji Wang; Yan Liu; Yang Liu; Yuan-Xi Huang; Da Pang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

5.  HOXD13 methylation status is a prognostic indicator in breast cancer.

Authors:  Zhenbin Zhong; Ming Shan; Ji Wang; Tong Liu; Bingshu Xia; Ming Niu; Yanlv Ren; Da Pang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

6.  Exploring the effects of gene dosage on mandible shape in mice as a model for studying the genetic basis of natural variation.

Authors:  Louis Boell; Luisa F Pallares; Claude Brodski; Yiping Chen; Jan L Christian; Youssef A Kousa; Pia Kuss; Sylvia Nelsen; Orna Novikov; Brian C Schutte; Ying Wang; Diethard Tautz
Journal:  Dev Genes Evol       Date:  2013-04-06       Impact factor: 0.900

7.  Hyperexpression of HOXC13, located in the 12q13 chromosomal region, in well‑differentiated and dedifferentiated human liposarcomas.

Authors:  Monica Cantile; Francesca Galletta; Renato Franco; Gabriella Aquino; Giosuè Scognamiglio; Laura Marra; Margherita Cerrone; Gabriella Malzone; Angela Manna; Gaetano Apice; Flavio Fazioli; Gerardo Botti; Annarosaria De Chiara
Journal:  Oncol Rep       Date:  2013-10-01       Impact factor: 3.906

8.  Spatiotemporal proteomic analyses during pancreas cancer progression identifies serine/threonine stress kinase 4 (STK4) as a novel candidate biomarker for early stage disease.

Authors:  Justin E Mirus; Yuzheng Zhang; Michael A Hollingsworth; Joell L Solan; Paul D Lampe; Sunil R Hingorani
Journal:  Mol Cell Proteomics       Date:  2014-09-15       Impact factor: 5.911

9.  Increased HOX C13 expression in metastatic melanoma progression.

Authors:  Monica Cantile; Giosuè Scognamiglio; Annamaria Anniciello; Marisa Farina; Giusy Gentilcore; Clemente Santonastaso; Franco Fulciniti; Clemente Cillo; Renato Franco; Paolo A Ascierto; Gerardo Botti
Journal:  J Transl Med       Date:  2012-05-14       Impact factor: 5.531

10.  HOX Gene Aberrant Expression in Skin Melanoma: A Review.

Authors:  Gérald E Piérard; Claudine Piérard-Franchimont
Journal:  J Skin Cancer       Date:  2012-10-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.